Development of a Novel Benzodiazepine to Delineate Peripheral GABA-A Signaling Mechanisms in Visceral Pain Syndromes
These findings highlight the potential of targeting peripheral GABRAs for pain management in disorders associated with visceral hypersensitivity.
Authors
- Pankaj J. Pasricha (ORCID: https://orcid.org/0000-0002-8727-683X)
- Adrienne C. DeBrosse
- Subhash Kulkarni (ORCID: https://orcid.org/0000-0002-2298-0623)
- Ingrid P. Buchler
- Michael S. Poslusney
- James C. Barrow (ORCID: https://orcid.org/0000-0001-5115-9300)
- Diane E. Peters (ORCID: https://orcid.org/0000-0003-4185-6203)
- Gregory V. Carr (ORCID: https://orcid.org/0000-0002-6091-6729)
- Yaohui Zhu (ORCID: https://orcid.org/0000-0003-4091-4782)
- Yifang Huang
- Noelle White
- Qian Li
- Liansheng Liu
Institutions
- Beth Israel Deaconess Medical Center (US)
- Mayo Clinic (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- Lieber Institute for Brain Development (US)
Publication Details
- Journal
- Cellular and Molecular Gastroenterology and Hepatology
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1016/j.jcmgh.2025.101704
- Citations
- 1
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 33.53